However, to point out how fast this industry is moving, in 2024 the combination trial designs are much different using (RANO).
Let me ask you this question. If it was your child, would you want to use DCVax-L alone, or would you want to use a combination therapy and (RANO) as described below?
So you now suggest RANO to evaluate endpoints for DCVax-L?